神经保护
脂质体
药理学
氧化应激
医学
药物输送
药品
细胞凋亡
抗氧化剂
缺血
冲程(发动机)
生物利用度
缺血性损伤
缺血性中风
再灌注损伤
缺血再灌注损伤
治疗效果
化学
脂质双层
病变
控制释放
磷脂
体内
神经科学
临床试验
作者
Yu Wang,Guan Wang,Xuenan Zhou,Xiaodi Zhang,Fang Li,Kexin Meng,Peng Wang,Jia Liang
标识
DOI:10.1021/acs.molpharmaceut.6c00493
摘要
18β-Glycyrrhetinic acid (GA) exhibits excellent anti-inflammatory and antioxidant activities, and has attracted considerable attention in the field of cerebral ischemia-reperfusion (I/R) injury therapy. However, it is plagued by problems of low bioavailability and dose-dependent toxicity. As a drug delivery platform for the treatment of ischemic stroke, microenvironment-responsive liposomes can cross the impaired blood-brain barrier, efficiently deliver drugs to the lesion sites, and improve therapeutic efficacy. Herein, to address the challenges posed by the highly oxidative-stress microenvironment of I/R and the intrinsic physicochemical properties of GA, we encapsulated GA into liposomes and incorporated thioketal (TK) linkages into the phospholipid bilayer to fabricate GA@TK-Lip. GA@TK-Lip can effectively target damaged neurons, attenuate neuroinflammation, scavenge excessive ROS, ameliorate cellular oxidative stress via the Nrf2/HO-1 pathway, reduce neuronal apoptosis and cerebral infarct volume to 43.2% and 23.3% of that in the MCAO group, and restore neurological function. Collectively, this study provides novel insights into the development of promising therapeutic strategies for ischemic stroke.
科研通智能强力驱动
Strongly Powered by AbleSci AI